Rubella revisited: Where are we on the road to disease elimination in Central Europe?Archived
Elimination of rubella and prevention of congenital rubella infection in Europe has been a high priority for the WHO European Regional Office over the past decade. In 2010 the WHO regional committee for Europe renewed its commitment to the elimination of rubella and prevention of CRS with a new target of 2015. For Central Europe to reach the target of rubella elimination and prevention of CRS by 2015, very high vaccine coverage levels need to be maintained and catch-up campaigns continued to address susceptible groups, in particular women of child-bearing age.
ECDC scientfic advance 2011-11-10
Usonis V, Anca I, André F, Chlibek R, Cižman M, Ivaskeviciene I, Mangarov A, Mészner Z, Perenovska P, Pokorn M, Prymula R, Richter D, Salman N, Simurka P, Tamm E, Tešović G, Urbančíková I. Vaccine. 2011 Nov 15;29(49):9141-7.
Seroprevalence of Measles-, Mumps- and Rubella-Specific IgG Antibodies in German Children and Adolescents and Predictors for SeronegativityArchived
16 Aug 2012 - This large population based sero-epidemiological study describes MMR seroprevalence as a whole and calculates independent predictors for seronegativity for measles, mumps and rubella antibodies in Germany.
Healthcare workers’ role in keeping MMR vaccination uptake high in Europe: a review of evidenceArchived
17 Jul 2012 - This review shows that doctors and other healthcare providers are regarded as the most reliable sources of information from parents